65,437 trials
Hereditary Angioedema
Primary: Incidence and Severity of Adverse Events, Number of Participants With Local Injection Site Reactions, and Number of Participants Who Discontinue Study Drug or Withdraw…
Lung Cancer
Primary: Response by RECIST Criteria (v 1.0) — 3; 5; 11; 15 participants
Osteoporosis
Primary: Percent Change in Intestinal Calcium Absorption — 34.2; 31.5 percentage of calcium absorption
Schizophrenia
Primary: Total Plasmalogen Levels in the Lipid Profile — 57.65; 59.57; 75 nmoles/gram — p=0.0149
Diabetes
Primary: Percent of Self-Test Fingerstick Blood Glucose Results Within +/- 5to15mg/dL (<100mg/dL) or Within +/- 5to15% (>=100mg/dL) of Laboratory Glucose Method — 100; 98.9; 100…
Melanoma (Skin)
Primary: Cytotoxic T-cell Lymphocytes (CTL) Response Rate — 43; 47; 28; 5 percentage of participants — p=<0.001
Carcinoma, Non-Small-Cell Lung (NSCLC)
Primary: Percentage of Participants With Objective Response (OR) — 39.5 Percentage of participants
Keloid Scar
Primary: To Assess the Impact of an Educational Lecture on Knowledge About Keloid Scars by Comparing Mean Scores Between Knowledge Assessment Questionnaires Administered Before…
Arthritis, Rheumatoid
Primary: Percentage of Participants Achieving American College of Rheumatology 20% (ACR20) Response at Week 12 — 31.48; 45.10; 61.22; 72.13 percentage of participants
HIV · AIDS · Peripheral Neuropathy
Primary: Pain Scores at Week 3 — 50.53; 53.76 units on a scale 0-100 (0= no pain)
Thrombosis
Primary: Major Bleeding — 0 participants
Carcinoma · Non Small Cell Lung
Primary: Overall Survival (OS) — 10.41; 10.05 months — p=0.8985
Macromastia
Primary: Postoperative Pain — 4.47; 4.66 units on a scale — p=0.4697
Healthy
Primary: Residual Urine Measured by Ultra Sound — 11; 6 ml — p=0.56
Urostomy Patent
Primary: Preference of the Two Urostomy Products — 21; 4 participants